Seeking Alpha

mikem1111

mikem1111
Send Message
View as an RSS Feed
View mikem1111's Comments BY TICKER:
Latest  |  Highest rated
  • Europe Embraces Groundbreaking Cancer Therapy [View article]
    Sharon,

    Good article. I have been long CVM for a while, more like a nightmare. Why does the Street hate it?
    Oct 28 09:07 AM | 1 Like Like |Link to Comment
  • The Bull Case For Pluristem Therapeutics [View article]
    Nsahbti,

    Good information. I agree that as long as PSTI brings home the "right stuff" it will have support.

    I am still trying to get the following idea addressed:
    PSTI has warrants selling around 33 cents now, up about 8 cents. They expire in 4 years. Are these a good way to invest in PSTI? Is there any downside to buying their warrants except for the time limit?
    Oct 23 10:11 AM | Likes Like |Link to Comment
  • Pluristem's Promising GvHD Indication Pits It Against Osiris [View article]
    Sharon,

    What do you think of the PSTI warrants? They have a 4 year window with a $5 base? Thanks.
    Oct 7 09:40 PM | Likes Like |Link to Comment
  • An Expanding Distribution Infrastructure Augurs Well For Atossa Genetics [View article]
    Do the Atossa warrants trade and are they a good investment?
    Oct 3 07:24 AM | Likes Like |Link to Comment
  • Celgene's And Osiris' IP Positions Weakened By Pluristem's Pivotal Patent [View article]
    PSTI has warrants that mature in 4 years. I believe you can trade 3 warrants for one share of stock. PSTI must be $5 or more for the warrants to be worth anything. Presently the sell for $0.32. Question, are these warrants a good bet? They rarely trade.
    Oct 2 01:28 PM | Likes Like |Link to Comment
  • Atossa Genetics Novel Test Could Generate Nice Profits [View article]
    ATOS now has a nice distribution contract. Impressive. How long will it take to see the tests' reception and consequent income to Atossa?
    Sep 23 09:24 AM | Likes Like |Link to Comment
  • Agenus: Some More Thoughts On The Potential For Prophage [View article]
    Your review of AGEN is terrific. I feel much better about my investment in the stock. Feuerstein thinks he knows it all and apparently many people agree with him. He can rip a stock and it will never survive, i.e., CVM.
    Thank you.
    Sep 23 09:20 AM | 1 Like Like |Link to Comment
  • The Bull Case For Pluristem Therapeutics [View article]
    Tofifon,

    Good points. However, about half of Zami Aberman's compensation is stock. If PSTI goes down the tubes (higly unlikely in my view), Zami's golden opportunity sinks too.
    Sep 12 09:13 AM | 1 Like Like |Link to Comment
  • The Bull Case For Pluristem Therapeutics [View article]
    Kankak,

    Very complete article. This is the second time I have read it. You write very clearly, effectively getting your ideas across.

    Question: PSTI has warrants selling around 25 cents. The expire in 4 years. Are these a good way to get started investing in PSTI? Is there any downside to buying their warrants except for the time limit?

    Thanks.
    Sep 12 02:10 AM | Likes Like |Link to Comment
  • Atossa Genetics' Portfolio Can Detect Breast Cancer, But Can These Products Eradicate It? [View article]
    As a follow-up to my efforts to identify how accepted Atos' tests are, I contacted the Am. CA Society. I spoke to a clinician whose job entails helping patients identify treatment etc. She told me that the ACS does not approve the ForeCyte test. Why, I think it is because the ACS does not like the way that the ForeCyte test gets its cells. ALSO, ACS contends that this test is not approved by the FDA. The ACS likes the mammogram. Tried and true, I guess. Thoughts?
    Jun 28 10:39 AM | Likes Like |Link to Comment
  • Atossa Genetics' Portfolio Can Detect Breast Cancer, But Can These Products Eradicate It? [View article]
    My wife called Vanderbilt Univ Medical center's Breatst Center and asked them about the ForeCYTE test. The physician with whom she spoke was non-plus. ForeCYTE may be a wonderful test but if it is not properly marketed, no one is going to prescribe it or request it. Atossa and its marketing partner need to get their tests out there if women's lives are to be saved.
    Jun 2 06:52 AM | Likes Like |Link to Comment
  • Atossa Genetics Novel Test Could Generate Nice Profits [View article]
    I found the following info from ATOS to be important:

    Payer Av Insurance Pay Av Patient Responsibility
    CIGNA $1,213 $99
    United Healthcare $912 $400
    Aetna $552 $760
    BCBS $412 $900

    Plus how uncomfortable is the ATOS test versus the mammogram?
    May 29 06:59 AM | Likes Like |Link to Comment
  • Atossa Genetics Novel Test Could Generate Nice Profits [View article]
    Are the ATOS tests approved by the FDA? If the tests are as credible as stated, why have they not replaced the mammagram? Are the ATOS tests expensive?
    May 3 12:35 PM | Likes Like |Link to Comment
  • Apricus Biosciences: A Transformative Year Ahead [View article]
    Chemistfrog,

    After APRI dropped below $3, I began to consider buying it. Did you ever buy a long position in the stock?
    Apr 19 11:13 AM | Likes Like |Link to Comment
  • Cel-Sci: Immunotherapy Opens New Door To Investors [View article]
    I spend much time in Israel on business. TEVA is considered a very smart!!! and important company. I believe that if TEVA was behind CVM it was a very good buy at 29 cents. I just bought more at 23 for the same reason and as a result of management's inside buying. However, insiders bought at higher amounts too and nothing happened. Does the CEO have a hidden agenda for us to buy at this low level?
    Apr 4 08:26 AM | Likes Like |Link to Comment
COMMENTS STATS
20 Comments
4 Likes